AbCellera Biologics (ABCL) Operating Income (2020 - 2026)
AbCellera Biologics (ABCL) posted Operating Income of -$57.5 million for Q1 2026, down 101.24% on a QoQ basis from -$28.6 million in Q4 2025, and up 8.2% year-over-year from -$53.2 million in Q1 2025.
AbCellera Biologics (ABCL) Operating Income (2020 - 2026) Analysis & Trends
AbCellera Biologics' Operating Income history runs 7 years deep, the most recent figure standing at -$57.5 million for Q1 2026.
- Quarterly Operating Income rose 8.2% year-over-year to -$57.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$212.0 million (up 34.28% YoY) and the FY2025 annual result came in at -$217.1 million, up 31.03% from the prior year.
- Operating Income was -$57.5 million for Q1 2026 at AbCellera Biologics, down from -$28.6 million in the prior quarter.
- Across five years, Operating Income topped out at $225.0 million in Q1 2022 and bottomed at -$93.7 million in Q3 2024.
- A 5-year average of -$35.9 million and a median of -$54.9 million in 2024 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income jumped 234.31% — and 2023, when it sank 512.07%.
- AbCellera Biologics' Operating Income stood at -$37.8 million in 2022, then plunged by 74.85% to -$66.1 million in 2023, then retreated by 10.15% to -$72.8 million in 2024, then surged by 60.71% to -$28.6 million in 2025, then plunged by 101.24% to -$57.5 million in 2026.
- Business Quant data shows ABCL's Operating Income at -$57.5 million in Q1 2026, -$28.6 million in Q4 2025, and -$76.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - | -57.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.52 Mn |
| Dec 31, 2025 | -28.58 Mn |
| Sep 30, 2025 | -76.28 Mn |
| Jun 30, 2025 | -49.59 Mn |
| Mar 31, 2025 | -62.66 Mn |
| Dec 31, 2024 | -72.76 Mn |
| Sep 30, 2024 | -93.66 Mn |
| Jun 30, 2024 | -93.45 Mn |
| Mar 31, 2024 | -54.89 Mn |
| Dec 31, 2023 | -66.05 Mn |
| Sep 30, 2023 | -54.89 Mn |
| Jun 30, 2023 | -51.39 Mn |
| Mar 31, 2023 | -64.87 Mn |
| Dec 31, 2022 | -37.78 Mn |
| Sep 30, 2022 | 37.74 Mn |
| Jun 30, 2022 | -8.40 Mn |
| Mar 31, 2022 | 224.95 Mn |
| Dec 31, 2021 | 81.55 Mn |
| Sep 30, 2021 | -28.10 Mn |
| Jun 30, 2021 | -7.03 Mn |